Focalin XR FDA Approval History
FDA Approved: Yes (First approved May 26, 2005)
Brand name: Focalin XR
Generic name: dexmethylphenidate
Dosage form: Extended-Release Capsules
Company: Novartis Pharmaceuticals Corporation
Treatment for: ADHD
Focalin XR (dexmethylphenidate) is a once-daily extended-release form of Focalin indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults, adolescents and children.
Development Timeline for Focalin XR
|Nov 12, 2008||FDA Approves 30-Minute Onset of Action for Focalin XR|
|May 26, 2005||Focalin XR Novartis Pharmaceuticals Corporation - Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.